Tigen is a Swiss biotech company in the field of cell therapies to cure cancer. A disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class capabilities and a long-term perspective to accelerate the access to novel T-cell therapies for patients and society.

Some insights